List of Studies ( Metabolite:CAR 17:1)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
|---|---|---|---|---|---|---|---|
| ST003108 | AN005089 | Complete absence of GLUT1 does not impair human terminal erythroid differentiation | Cultured cells | Human | GLUT1 Deficiency Syndrome | University of Colorado | area |
| ST003051 | AN005002 | Shotgun lipidomics of breast cancer endocrine therapy persisters | Breast cancer cells | Human | Cancer | Dartmouth College | counts |
| ST003417 | AN005616 | Relative concentrations of acylcarnitines in BT-474 cells treated with FASN inhibitors TVB-2640 and TVB-3166 | Breast cancer cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
| ST003434 | AN005642 | Plasma concentrations of Fasnall in mice after a bolus of 10 mg/kg administered intraperitoneally. | Blood | Human | Cancer | Wistar Institute | Counts per second (cps) |
| ST003435 | AN005644 | Metabolomics analysis of zebrafish embryos treated with rotenone, Fasnall, TVB-2640, and GSK2194069 | Media | Zebrafish | Cancer | Wistar Institute | Counts per second (cps) |
| ST003436 | AN005646 | Pharmacokinetics of Fasnall in NSG mice | Blood | Mouse | Cancer | Wistar Institute | Counts per second (cps) |
| ST003436 | AN005646 | Pharmacokinetics of Fasnall in NSG mice | Brain | Mouse | Cancer | Wistar Institute | Counts per second (cps) |
| ST003436 | AN005646 | Pharmacokinetics of Fasnall in NSG mice | Heart | Mouse | Cancer | Wistar Institute | Counts per second (cps) |
| ST003436 | AN005646 | Pharmacokinetics of Fasnall in NSG mice | Liver | Mouse | Cancer | Wistar Institute | Counts per second (cps) |
| ST003222 | AN005283 | A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation - Part 1 | Heart | Mouse | Ischemia | University of Mississippi Medical Center | lipid content in the sample (nmol/g) |
| ST003349 | AN005489 | An integrated LC-MS analysis of the biometric characteristics of different time cohorts of race walkers - targeted | Blood | Human | The First Affiliated Hospital of Dalian Medical University | ng/mL | |
| ST003390 | AN005563 | In-depth profiling of biosignatures for Type 2 diabetes mellitus cohort utilizing an integrated targeted LC-MS platform | Blood | Human | Diabetes | The First Affiliated Hospital of Dalian Medical University | ng/mL |
| ST003241 | AN005309 | Lipidomic analysis of lung from Gclc WT and whole-body Gclc KO mice. | Lung | Mouse | Oxidative stress; Stress | University of Rochester Medical Center | Normalized to the median value of total lipid signals |
| ST003242 | AN005311 | Lipidomic analysis of kidney from Gclc WT and whole-body Gclc KO mice. | Kidney | Mouse | Oxidative stress; Stress | University of Rochester Medical Center | Normalized to the median value of total lipid signals |
| ST002153 | AN003527 | Data from plasma metabolome analysis of APP-KI and Wild type mice treated with B. breve MCC1274 | Blood | Mouse | Morinaga milk industry CO., LTD. | peak area | |
| ST002631 | AN004303 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Plasma - Untargeted Lipidomics, Reversed-Phase Positive | Blood | Rat | Georgia Institute of Technology | peak area | |
| ST002637 | AN004309 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Hippocampus Powder - Untargeted Lipidomics, Reversed-Phase Positive | Hippocampus | Rat | Georgia Institute of Technology | peak area | |
| ST002678 | AN004350 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Liver Powder - Untargeted Lipidomics, Reversed-Phase Positive | Liver | Rat | Georgia Institute of Technology | peak area | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001442 | AN002410 | Human Optic Nerve Glaucoma and Control Lipidomes | Eye tissue | Human | Eye disease | University of Miami | Peak area |
| ST002505 | AN004126 | A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) | Cultured cells | Human | Cancer | University of Science and Technology of China | Peak area |
| ST003128 | AN005129 | Effect of high fat diet on serum lipidome and metabolome in CHCHD10 Mutant Mice | Blood | Mouse | Cardiomyopathy | Weill Cornell Medicine | Peak Intensity |
| ST003326 | AN005449 | Lipidome profiling in non-alcoholic steatohepatitis identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism | Liver | Mouse | Liver disease | University of Melbourne | pmol/mg tissue |
| ST001668 | AN002722 | D-Allulose effects on hepatic metabolomics profile in rodents | Liver | Rat | Matsutani Chemical Industry Co., Ltd. | Relative Area | |
| ST002522 | AN004155 | Lipidomics study on the effect of LBP protein on hepatic lipid composition in mice | Liver | Mouse | Oxidative stress | Department of Endocrinology and Laboratory for Diabetes, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China | Relative intensity |
